Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or immediate future fundraising through debt or equity in the provided transcript. The company recently raised funds through QIP proceeds amounting to INR 8,798 million, which were fully utilized for repayment of borrowings and funding working capital. A preferential allotment of INR 2,000 million was also made to enhance financial position. The management indicated a disciplined approach to managing financial obligations and highlighted a healthy cash balance of INR 3,605 million. Capex plans totaling around INR 300 crores are to be spent judiciousl

Any current/future capex/capital investment/strategic investment?

Planned capex of roughly INR 300 crores including Hi-Tech plants. Current strategy is to optimize production facilities and increase capacity without immediate heavy capex. Aim to leverage existing assets before committing significant investments. Not in a hurry to spend the full INR 300 crores; expected to be spent judiciously over 3-5 years. No major growth capex planned for existing RHI Magnesita India plants (Bhiwadi, Vizag, Cuttack). Recent expansions at Vizag (INR 55-60 crores spent last year) and Cuttack (expanded from 18kt to 30kt capacity). Focus on optimizing production footprint (e.

Future growth expectations in sales/revenue/volumes?

Industry expected to experience robust growth driven by steel, cement, glass, non-ferrous sectors. Growth supported by government infrastructure initiatives and budget policies. Company focusing on both organic and inorganic growth strategies to meet rising demand. Acquisitions of DOCL and Hi-Tech Chemicals expand production capacity and diversify product portfolio. Integration synergies improving revenue and EBITDA margins. Capacity optimization and planned capex of ~INR300 crores over 3-5 years to improve production without rushed spending. Efforts to increase in-house manufacturing (current

Future growth expectations in earnings/operating earnings/profits/EPS?

The company targets sustainable EBITDA margins around 14%-15% on a consolidated basis, acknowledging challenges especially due to lower margins from acquisitions like Dalmia. (Page 11) Management aims to increase EBITDA margins over the medium term through synergies from acquisitions and growth in higher-margin segments like flow control, which showed margin improvement from 15.8% to 20%. (Page 6) Revenue growth is expected between INR 4,000 to 4,500 crores for FY24, though softening steel prices and price reductions may impact the top line adversely. (Page 6) Refractory Management Services (R

IN US

Sale is live|00:00:00left today

RHI Magnesita India LtdQ2 FY23Industrial Products

RHI Magnesita India Ltd Q2 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹373P/E: 46.8Market Cap: ₹8.0K CrSector: Industrial Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→Industry expected to experience robust growth driven by steel, cement, glass, non-ferrous sectors.
→Growth supported by government infrastructure initiatives and budget policies.
→Company focusing on both organic and inorganic growth strategies to meet rising demand.
→Acquisitions of DOCL and Hi-Tech Chemicals expand production capacity and diversify product portfolio.
→Integration synergies improving revenue and EBITDA margins.
→Capacity optimization and planned capex of ~INR300 crores over 3-5 years to improve production without rushed spending.
→Efforts to increase in-house manufacturing (currently 76% of sales volume) aiming to reduce outsourcing gradually.
→Refractory Management Services (RMS) business growing; currently 31% of consolidated revenue.
→Exports expected to increase gradually from current 11%.
→Conservative revenue forecast for FY24 around INR4,000+ crores despite price pressures; volume growth expected to support topline.

Margin guidance

Category 3

→The company targets sustainable EBITDA margins around 14%-15% on a consolidated basis, acknowledging challenges especially due to lower margins from acquisitions like Dalmia. (Page 11)
→Management aims to increase EBITDA margins over the medium term through synergies from acquisitions and growth in higher-margin segments like flow control, which showed margin improvement from 15.8% to 20%. (Page 6)
→Revenue growth is expected between INR 4,000 to 4,500 crores for FY24, though softening steel prices and price reductions may impact the top line adversely. (Page 6)
→Refractory Management Services (RMS) business, contributing 31% of revenues consolidated, is targeted for growth, which typically carries better than normal supply margins, providing margin stability. (Page 14)
→Capex focused on optimizing existing capacities with INR 300 crore planned over 3-5 years, emphasizing margin improvement before large spend. (Page 9)
→Management maintains a disciplined approach to balancing growth and margin expansion with ongoing customer support and contract negotiations to manage price pressures. (Page 15)

3 more insights locked — sign up free to unlock

Fundraise plans

Yes

→There is no explicit mention of any current or immediate future fundraising through debt or equity in the provided transcript.
→The company recently raised funds through QIP proceeds amounting to INR 8,798 million, which were fully utilized for repayment of borrowings and funding working capital.
→A preferential allotment of INR 2,000 million was also made to enhance financial position.
→The management indicated a disciplined approach to managing financial obligations and highlighted a healthy cash balance of INR 3,605 million.
→Capex plans totaling around INR 300 crores are to be spent judiciously over 3-5 years, with no urgent need for additional debt or equity mentioned.
→No specific plans for new fundraising via debt or equity were discussed or indicated in this call.

Order book

The transcript provided on pages 14-15 does not contain specific details about the current or expected order book or pending orders for RHI Magnesita India Limited. The discussion primarily covers aspects such as long-term contracts, pricing negotiations, capacity utilization, margins, and financial performance. Key points related to order visibility and contracts: - Long-term contracts are typically for three years with annual price negotiations based on certain formulas. - The company emphasizes stronger relationships with customers supporting mutual adjustments as needed. - Sole-supplier contracts (e.g., with Sunflag for 22 years) provide assured volumes and reduce competition. - There is no explicit quantitative data provided about the current or expected order book or pending orders in the transcript. If you need a detailed breakdown of the order book, it is not available in this transcript.

Capex plans

→Planned capex of roughly INR 300 crores including Hi-Tech plants.
→Current strategy is to optimize production facilities and increase capacity without immediate heavy capex.
→Aim to leverage existing assets before committing significant investments.
→Not in a hurry to spend the full INR 300 crores; expected to be spent judiciously over 3-5 years.
→No major growth capex planned for existing RHI Magnesita India plants (Bhiwadi, Vizag, Cuttack).
→Recent expansions at Vizag (INR 55-60 crores spent last year) and Cuttack (expanded from 18kt to 30kt capacity).
→Focus on optimizing production footprint (e.g., shifting production closer to demand centers to gain margin synergies).
→Emphasis on increasing local manufacturing and reducing outsourcing gradually over the next 3-4 years.

How does RHI Magnesita India Ltd rank vs peers in Industrial Products?

Pro feature

1RHI Magnesita India Ltd

Rev 3Mar 3

See full Industrial Products sector rankings

Want more stocks like RHI Magnesita India Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio